Return to search

Kleiner Backs Antiviral Startup

3-V Biosciences Inc., a Menlo Park, Calif.-based developer of antiviral drugs to fight influenza virus, respiratory syncitial virus and rhinovirus, has raised $7.61 million in Series A funding, according to a regulatory filing. Backers include Kleiner Perkins Caufield & Byers, The Column Group and Wilson Sonsini.